These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38485465)

  • 21. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
    Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
    J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the
    H A Kankanamalage P; Hoerres R; Ho KV; Anderson CJ; Gallazzi F; Hennkens HM
    Nucl Med Biol; 2022; 108-109():1-9. PubMed ID: 35144046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RadioLabeling of the Mutant form of Anti-PlGF Nanobody by
    Rezazadeh T; Tabatabaee Bafroee AS; Shahhosseini S; Jokar S; Hasanramezani A; Arezumand R
    Iran J Pharm Res; 2024; 23(1):e144901. PubMed ID: 39108651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
    Schibli R; La Bella R; Alberto R; Garcia-Garayoa E; Ortner K; Abram U; Schubiger PA
    Bioconjug Chem; 2000; 11(3):345-51. PubMed ID: 10821650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death.
    Tavaré R; Torres Martin De Rosales R; Blower PJ; Mullen GE
    Bioconjug Chem; 2009 Nov; 20(11):2071-81. PubMed ID: 19874007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of a
    Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM
    Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Labeling of epirubicin with technetium-99m: Optimization, biodistribution and scintigraphic imaging in tumor bearing mice.
    Hina S; Bokhari TH; Roohi S; Rajoka MI; Sohaib M
    Pak J Pharm Sci; 2018 Mar; 31(2):517-524. PubMed ID: 29618443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
    Goins B; Bao A; Phillips WT
    Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A HER2-targeted RNA aptamer molecule labeled with 99mTc for single-photon imaging in malignant tumors.
    Varmira K; Hosseinimehr SJ; Noaparast Z; Abedi SM
    Nucl Med Biol; 2013 Nov; 40(8):980-6. PubMed ID: 23953624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and
    Okarvi SM; Aljammaz I
    Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative
    He J; Feng J; Su Y; Seo Y; Liu B
    Bioconjug Chem; 2020 Jul; 31(7):1750-1755. PubMed ID: 32628464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.
    Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X
    Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
    Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
    J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method.
    Yun H; Kim SH; Kim SH; Park HM; Jeong HJ
    Biotechnol J; 2024 Jul; 19(7):e2300745. PubMed ID: 39014926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an Anti-HER2 Single-Chain Variable Antibody Fragment Construct for High-Yield Soluble Expression in
    Byun KT; Kim B; Cho J; Lee I; Lee MG; Park D; Kang TB; Won HS; Kim CG
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New small
    Sabahnoo H; Noaparast Z; Abedi SM; Hosseinimehr SJ
    Eur J Med Chem; 2017 Feb; 127():1012-1024. PubMed ID: 27842890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical Evaluation of
    Oroujeni M; Rinne SS; Vorobyeva A; Loftenius A; Feldwisch J; Jonasson P; Chernov V; Orlova A; Frejd FY; Tolmachev V
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803361
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.